We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+15.46%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.97B
AUM Growth
+$823M
Cap. Flow
+$400M
Cap. Flow %
8.04%
Top 10 Hldgs %
46.77%
Holding
94
New
22
Increased
21
Reduced
16
Closed
33

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$384M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$238M
3
AGN
Allergan plc
AGN
+$175M
4
MDVN
MEDIVATION, INC.
MDVN
+$122M
5
AMZN icon
Amazon
AMZN
+$105M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$174M
2
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
+$106M
3
GILD icon
Gilead Sciences
GILD
+$106M
4
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
+$104M
5
DG icon
Dollar General
DG
+$103M

Sector Composition

Rank Sector Weight
1 Healthcare 39.81%
2 Communication Services 12%
3 Real Estate 9.46%
4 Energy 7.24%
5 Industrials 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HNT
26
DELISTED
HEALTH NET INC
HNT
$73.5M 1.48%
2,477,835
+1,440,056
+139% +$43.1M
TMO icon
27
Thermo Fisher Scientific
TMO
$214B
$71.3M 1.43%
640,428
-1,748,818
-73% -$174M
CME icon
28
CME Group
CME
$93.7B
$71M 1.43%
+905,252
New +$70.9M
CTRA
29
DELISTED
Coterra Energy
CTRA
$67.7M 1.36%
+1,747,597
New +$62.4M
BIDU icon
30
Baidu
BIDU
$35.6B
$60.9M 1.22%
342,395
-368,004
-52% -$59.5M
MPC icon
31
Marathon Petroleum
MPC
$89.6B
$55M 1.11%
+1,198,944
New +$46.1M
MHFI
32
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$52.1M 1.05%
+666,475
New +$47.8M
AGN
33
DELISTED
Allergan Inc
AGN
$50.1M 1.01%
+450,950
New +$43.1M
PARA
34
DELISTED
Paramount Global Class B
PARA
$41.5M 0.83%
650,968
-1,684,644
-72% -$99.1M
AUXL
35
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$40.3M 0.81%
1,943,672
+632,655
+48% +$11.9M
NFLX icon
36
Netflix
NFLX
$306B
$39.9M 0.8%
7,586,670
+88,970
+1% +$437K
THC icon
37
Tenet Healthcare
THC
$22B
$39.4M 0.79%
935,335
+474,608
+103% +$20.7M
WDAY icon
38
Workday
WDAY
$39.3B
$35.3M 0.71%
+424,785
New +$33.5M
KYTH
39
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$31.1M 0.62%
831,840
+63,948
+8% +$2.65M
OREX
40
DELISTED
Orexigen Therapeutics, Inc.
OREX
$28.4M 0.57%
504,712
+146,378
+41% +$8.23M
RPRX
41
DELISTED
Repros Therapeutics Inc.
RPRX
$28.2M 0.57%
1,540,091
+788,300
+105% +$14.9M
PFE icon
42
Pfizer
PFE
$144B
$25.6M 0.51%
880,188
-2,758,675
-76% -$80.3M
COO icon
43
Cooper Companies
COO
$14B
$23.7M 0.48%
764,612
+386,444
+102% +$12.3M
KPTI icon
44
Karyopharm Therapeutics
KPTI
$158M
$19.8M 0.4%
+59,301
New +$16.4M
BRKR icon
45
Bruker
BRKR
$9.48B
$19.5M 0.39%
988,190
-164,914
-14% -$3.23M
MCK icon
46
McKesson
MCK
$103B
$18.9M 0.38%
117,117
+7,609
+7% +$1.17M
ANAC
47
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$17.7M 0.36%
+1,055,014
New +$14.6M
HUM icon
48
Humana
HUM
$46.3B
$13.7M 0.27%
132,430
+7,609
+6% +$745K
REGN icon
49
Regeneron Pharmaceuticals
REGN
$72.2B
$13.4M 0.27%
48,771
-194,151
-80% -$55.8M
ILMN icon
50
Illumina
ILMN
$29B
$10.4M 0.21%
+96,713
New +$8.86M
1
2
3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q4 2013 Portfolio in Review

As of Q4 2013, PFM Health Sciences held 94 positions worth $4.97B, up 20% from $4.15B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

PFM Health Sciences deployed $400M of net new capital in Q4 2013, opening 22 new positions and adding to 21 existing holdings. Its largest new stake was Bristol-Myers Squibb: 7,532,007 shares worth $400M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 34% a quarter earlier, followed by Communication Services and Real Estate.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $174M trimmed.

  • PFM Health Sciences's largest Q4 2013 buy was Bristol-Myers Squibb: 7,532,007 shares worth $400M.
  • PFM Health Sciences added most to Allergan plc in Q4 2013, an estimated $175M increase.
  • PFM Health Sciences's biggest Q4 2013 reduction was Thermo Fisher Scientific, cutting an estimated $174M.
  • PFM Health Sciences fully exited CAMERON INTERNATIONAL CORPORATION in Q4 2013, selling an estimated $106M.
  • PFM Health Sciences's ten largest holdings make up 47% of its $4.97B portfolio in Q4 2013.
  • PFM Health Sciences opened 22 new positions and closed 33 in Q4 2013.
  • PFM Health Sciences's portfolio value rose 20% quarter-over-quarter to $4.97B.

Based on PFM Health Sciences's 13F filing for Q4 2013, filed 14 Feb 2014.